ADRIAN GOTTSCHALK - 22 Jan 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Adrian Gottschalk
Issuer symbol
FHTX
Transactions as of
22 Jan 2025
Net transactions value
+$1,748,000
Form type
4
Filing time
24 Jan 2025, 16:10:43 UTC
Previous filing
25 Jan 2024
Next filing
10 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $1,748,000 +400,000 $4.37 400,000 22 Jan 2025 Common Stock 400,000 $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.